Skip to content
Stock · yahoo

vVARDIS Holding AG

VVVV

$14.55
▼ 0.45 (-3%)
polled

New listing · first traded Nov 13, 2026 on NYSE · source: SEC EDGAR

Below: live stock price for vVARDIS Holding AG (VVVV), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.

vVARDIS Holding AG (VVVV) is a Healthcare company based in Switzerland. Operating in Medical Instruments & Supplies, it employs about 153 people. Over the past year VVVV traded between 14 and 16.95 USD.

Day
-3.00%
-0.45
Week
-11.82%
-1.95
Month
—
Year
—
Prev close
$15.00
Volume (24h)
$4.97M
Market cap
$770.91M
Currency
USD

Scoreas of Nov 21, 2026

38/ 100 · Weak

Coverage: 5/7
  • Value—
  • Quality50
  • Momentum25
  • Growth100
  • Risk—
  • Dividend0
  • Liquidity14

Composite of public market data. Informational only — not investment advice.

Trend projection

Not enough history to project a trend.

Interpretation

The composite score is in the weak range. Strength: growth with weakness: dividend.

Descriptive observation — not investment advice.

Score breakdown

Raw values behind each pillar so you can see what the composite is reading.

  • Quality
    50/100

    Quality looks mixed — driven by Profit margin (-105.16%).

    Profit margin:-105.16%Gross margin:85.39%
  • Momentum
    25/100

    Momentum looks fragile — driven by 52w change (-11.82%).

    52w change:-11.82%
  • Growth
    100/100

    Growth looks strong — driven by Revenue growth (214.20%).

    Revenue growth:214.20%
  • Dividend
    0/100

    Dividend looks fragile — driven by Dividend yield (0.00%).

    Dividend yield:0.00%
  • Liquidity
    14/100

    Liquidity looks fragile — driven by Current ratio (0.96).

    Current ratio:0.96Quick ratio:0.59

Derived from public market data — informational, not investment advice.

Pivot points

Daily, from the November 20 session's high, low and close

High 14.97 · Low 14.54 · Close 14.55

LevelClassicFibonacciCamarilla
R315.2615.1214.67
R215.1214.9514.63
R114.8314.8514.59
Pivot14.6914.6914.69
S114.4014.5214.51
S214.2614.4214.47
S313.9714.2614.43

Pivot points are reference levels computed with standard formulas from the previous session's range. They are not a forecast and not a buy or sell signal.

Weekly and monthly pivots, Woodie and DeMark: pivot point calculator →

Historical data

Daily prices for the latest sessions, newest first

DateCloseOpenHighLowVolumeChange %
Nov 20, 202614.5514.8914.9714.544.97M-3.00%
Nov 19, 202615.0015.5016.1214.967.28M-3.04%
Nov 18, 202615.4715.7515.8815.405.14M-2.09%
Nov 17, 202615.8015.7516.2915.682.55M-1.25%
Nov 16, 202616.0016.0716.9515.9510.82M-3.03%

Financials

52w high
$16.95
52w low
$14.00
52w change
-11.82%
Day high
$14.97
Day low
$14.54
Enterprise value
612.5M
EV / Revenue
12.33
EV / EBITDA
-20.56
EPS (TTM)
-$0.29
Dividend yield
0.00%
Revenue (TTM)
49.68M
EBITDA
-29.79M
Total cash
28.97M
Total debt
86.37M
Current ratio
0.96
Quick ratio
0.59
Profit margin
-105.16%
Gross margin
85.39%
Shares outstanding
38.59M
Float
2.96M
Sector: HealthcareIndustry: Medical Instruments & SuppliesHQ: SwitzerlandEmployees: 153www.vvardis.com

vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel. The company was incorporated in 2020 and is based in Zug, Switzerland. vVARDIS Holding AG operates as a subsidiary of VVARDIS Investment Holding AG.

Analyst & Risk

Consensus

Analysts' consensus via Yahoo Finance — not investment advice.

No consensus available.
Analyst price target
—
Mean target · ? analysts
52-week change
-11.82%
Current ratio
0.96
Quick ratio
0.59
EV / Revenue
12.33
EV / EBITDA
-20.56
Revenue growth
214.20%
EBITDA
-29.79M
Total cash
28.97M
Total debt
86.37M
Insider holdings
146.04%
Institutional
0.00%

Analyst estimates

Consensus of research analysts' forecasts, compiled by Yahoo Finance · as of Nov 21, 2026

Estimates by period
PeriodEPS estimateEPS vs a year earlierRevenue estimateRevenue vs a year earlier
Current quarter——0range 0 – 00 analysts—
Next quarter——0range 0 – 00 analysts—
Current fiscal year——0range 0 – 00 analysts—
Next fiscal year——0range 0 – 00 analysts—

Recent news

Related

Other assets in this category.

Learn the terms

Live discussion

Sign in to join the discussion.

  • Loading…